Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
about
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersThe mutational landscape of hepatocellular carcinomaPrognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospectsLiver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafishIntegration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomasMutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype.CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesisCRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.Deciphering cancer heterogeneity: the biological space.Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma.iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models.Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.Molecular classification of prostate cancer using curated expression signaturesMolecular Determinants of Prognosis in Hepatocellular Carcinoma.Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.Distance in cancer gene expression from stem cells predicts patient survival.A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy.Cancer stem cells in the development of liver cancerRole of methionine adenosyltransferase genes in hepatocarcinogenesisThe sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.Identification of driver genes in hepatocellular carcinoma by exome sequencing.Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patientsTP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis.TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.Perspectives of integrative cancer genomics in next generation sequencing era.Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers.Effects of Mutations of 3 Amino Acids on Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.p53 in liver pathologies-taking the good with the bad.Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks.Effect of Over-Expression of Zinc-Finger Protein (ZFX) on Self-Renewal and Drug-Resistance of Hepatocellular Carcinoma.Clinical Outcomes of TP53 Mutations in Cancers.Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines.Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.The role of cellular senescence in the gastrointestinal mucosa.XRCC1 rs25487 genetic variant and TP53 mutation at codon 249 predict clinical outcomes of hepatitis B virus-related hepatocellular carcinoma after hepatectomy: A cohort study for 10 years' follow up.
P2860
Q26741204-4745E6F1-1BB9-426C-AF91-E95CA1620D91Q26777478-04E74E14-BC8D-4D46-BDB1-3A5A07A2053EQ27021265-D4E78C2E-374F-4751-882D-79A54E35E502Q28534280-75294139-BD26-433C-888F-1D427107A2EEQ28649881-2FAC044A-1A41-412F-B410-6B72CA0F0478Q33618512-7532EF00-2E09-4581-8A04-2FC9BB02AEB4Q33733021-D6450F0D-4652-4DC5-B348-E595B01B02A6Q33765935-E28853D7-308A-4AEE-9337-7322DAA63F08Q34391327-C20C94D0-4A69-4674-A084-A1321D633DBEQ34734133-3B4D3C10-950D-4ED6-8BD3-FF58C8F1D4C4Q35041003-A0EC687F-EB34-43A7-BB8E-916035EC4168Q35048768-47FB589C-1453-4489-AB1B-32C0D0E882C7Q35111116-956C20A0-1040-4E78-B4A4-E8482F9B854EQ35605993-BD8F18F4-EA40-4657-B9EA-7B5F9AF4CCDDQ35641563-ABB98565-2C2B-49D5-B4CD-B8BD1F7C101BQ35905975-585B574A-6241-4706-91B5-F7D2CE0D2A38Q36279142-7E8737D3-86F1-47FA-B32B-D41BCBB1AEC4Q36319754-F8C4BAAF-EB79-4DBC-9BF5-662061C221E1Q36502944-6BFD9A16-DD50-4545-9578-24C710362401Q36793453-2550EC57-C613-4B11-A3C4-FED759B9D3B1Q37132635-F9E1FA02-EFE5-4C92-99A0-8ED661210099Q37211959-EE4111A6-F49F-44DD-B6F4-C08848163B8AQ37295260-4DB115B4-FDE3-4C0C-B844-D868AF4F1266Q37315447-6C1D1ACD-7974-46BB-A09C-E86235F43364Q37496567-AEA9DA27-6891-4085-96FD-BF3B84F923A2Q37584718-005932FC-9581-47BD-946F-3A5927626843Q37722129-329B298C-7906-40C3-94DD-C0E3CBDD0E42Q38056125-A91308EB-1729-44A5-84F1-6C3C5E5B79BBQ38155513-2EF891B9-D6D9-48A3-AD97-6B33D35E287EQ38254776-87A31629-5504-4073-AED1-9480475C90EEQ38268953-4A4D416C-EDB1-436E-9C7B-907260256232Q38436698-6FF736ED-1B39-4E21-876D-C1C0B98F63C8Q38749763-00EBCD5C-C764-4D9A-9D93-8A72B7AB2543Q38906201-538B51FB-2BB5-4444-B932-234B66EF6444Q38923977-C24D9400-09E3-4AD0-B447-97B606DB705BQ39019365-1676CC9C-2F07-4320-A22A-7747FC8074EEQ39098398-335F55B4-C3FC-432E-A55D-1C4750CFDC65Q40354630-C28A472B-DA46-4BF8-93AE-8DC670681591Q40956746-5BB07E24-1F7D-4FBE-9C31-7ACF4CE2CDF0Q41165640-FC43C983-9930-4972-9B93-8274392E4194
P2860
Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of TP53 mutations ...... with hepatocellular carcinoma.
@ast
Association of TP53 mutations ...... with hepatocellular carcinoma.
@en
Association of TP53 mutations ...... with hepatocellular carcinoma.
@nl
type
label
Association of TP53 mutations ...... with hepatocellular carcinoma.
@ast
Association of TP53 mutations ...... with hepatocellular carcinoma.
@en
Association of TP53 mutations ...... with hepatocellular carcinoma.
@nl
prefLabel
Association of TP53 mutations ...... with hepatocellular carcinoma.
@ast
Association of TP53 mutations ...... with hepatocellular carcinoma.
@en
Association of TP53 mutations ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Association of TP53 mutations ...... with hepatocellular carcinoma
@en
P2093
Anuradha Budhu
Curtis C Harris
Snorri S Thorgeirsson
So Mee Kwon
Xin Wei Wang
Yun Hee Kim
Zhao-You Tang
Zongtang Sun
P2860
P304
P356
10.1053/J.GASTRO.2010.11.034
P407
P50
P577
2010-11-19T00:00:00Z